Korean biotech company Panagene plans to apply for regulatory approval of its own liquid biopsy testing in the US this year with aims to compete head-on with its bigger rival Roche.“I’m confident Panagene’s testing technology is more advanced than that of Roche,” Panagene CEO Kim Sung-kee told The Investor in a re...
[THE INVESTOR] The top executive of the International Air Transport Authority encouraged Korea to ratify an international agreement laying out the legal responsibilities following incidents with unruly passengers on flights.“We encourage Korea to sign MP14,” IATA Director General Alexandre de Juniac told reporters on April 24 at the 2017 IATA Safety and Flight Ops Conference ongoing at the Grand Hyatt Seoul. IATA Director General and CEO Alexandre de Juniac speaks at the 2017 IATA Safety and Fl
[THE INVESTOR] Celltrion and its retail partner Pfizer plan to complete switching studies of the Korean drug maker’s biosimlar Inflectra, known as Remsima in Europe, to demonstrate its interchangeability with the original drug Remicade by the end of this year, industry sources said on April 25. Inflectra, referencing Johnson & Johnson’s blockbuster autoimmune disease treatment Remicade, made its US debut in November last year but sales are still lukewarm. Related: [INSIDE CELLTRION] Celltrion’s
[THE INVESTOR] SsangYong Motor, owned by Indian auto giant Mahindra & Mahindra, on April 25 said it aims to sell 20,000 units of its new large G4 Rexton sport utility vehicle in Korea this year. “This year, we plan to sell 20,000 units of G4 Rexton, taking into account that sales will begin in May,” Maing Jin-soo, marketing manager of SsangYong, told reporters at a press event held in Seoul. “Next year, we are confident of selling 30,000 units.”The G4 Rexton made its world premiere at the Seoul
[THE INVESTOR] Korean biotech company Panagene plans to apply for regulatory approval of its own liquid biopsy testing in the US this year with aims to compete head-on with its bigger rival Roche.“I’m confident Panagene’s testing technology is more advanced than that of Roche,” Panagene CEO Kim Sung-kee told The Investor in a recent interview on April 21. “We will take on Roche when the market is fully opened.” Panagene CEO Kim Sung-kee Lee Sang-sub/The InvestorPhy
[THE INVESTOR] Hyundai Motor has entered the final testing of its high-performance hatch i30 N ahead of its global launch in the second half of this year, the automaker said on April 24. Hyundai raced two i30 N cars at the ADAC Qualification Race 24H at the famous Nurburgring circuit in Germany on April 22-23. The six-hour endurance race is a dress rehearsal to the upcoming ADAC Zurich 24-hour Race in May, which Hyundai will participate in. “We will continue to participate in 24-hour endurance r
[THE INVESTOR] Low-cost carrier Jin Air, owned by the nation's largest airline company Korean Air, said on April 25 it aims to make a stock debut by the end of this year. The company also announced it has named Mirae Asset Daewoo as the lead counsel for the listing plans. Jin Air, marking its 10th anniversary next year, has set a 1 trillion won (US$887 million) revenue target for 2018, expanding its fleet to 30 and routes to 55. Established in 2008, Jin air currently is the only low-cost carrier
[THE INVESTOR] Hyundai Motor Vice Chairman Chung Eui-sun on April 24 left for Beijing to address the carmaker’s faltering Chinese sales amid heightened political tension between Korea and China over the deployment of US-led THAAD missile system, according to media reports. Chung is planning to inspect Hyundai’s auto plants in Beijing, as well as reevaluate its business plans. Company officials weren’t available for comment. Hyundai and its sister company Kia Motors’ sales in China plummeted 52.
[THE INVESTOR] Lotte's ousted vice chairman Shin Dong-joo is seeking to regain power at his family’s conglomerate as his younger brother, Lotte Group Chairman Shin Dong-bin , is caught in a web of legal troubles. Speaking to media in Tokyo on April 21, the elder Shin said that he will be asking Lotte Holdings to reinstate him as a member of the board at the regular shareholders‘ meeting scheduled for the end of June. “I am concerned about Lotte Group’s future and will continue to work towards